Loading...
XASXHXL
Market cap1mUSD
Oct 24, Last price  
0.01AUD
Name

Hexima Ltd

Chart & Performance

D1W1MN
XASX:HXL chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
20.73%
Rev. gr., 5y
%
Revenues
0k
-100.00%
0003,252,0874,440,0864,801,6272,254,2371,806,5231,737,146797,67988,1844,082,0295,810,7081,484,7590
Net income
-934k
L-51.33%
-3,029,909-11,276,023-6,118,978-2,849,898-2,427,859-2,082,307-1,939,008-1,856,202-1,951,228-2,895,532-3,625,762-6,873,646-10,020,761-1,918,886-933,873
CFO
-162k
L-90.82%
000-2,859,602-2,534,264-1,649,372-1,445,354-1,124,755-2,189,537-1,628,595-2,096,512-5,792,242-9,756,275-1,763,285-161,901

Profile

Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.
URL
https://hexima.com.au/
IPO date
Dec 01, 2020
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
1,485
-74.45%
5,811
42.35%
Cost of revenue
3,284
15,112
Unusual Expense (Income)
NOPBT
(1,800)
(9,301)
NOPBT Margin
Operating Taxes
(62)
(1,177)
5,924
Tax Rate
NOPAT
62
(622)
(15,225)
Net income
(934)
-51.33%
(1,919)
-80.85%
(10,021)
45.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
(4)
9,668
BB yield
0.10%
-211.06%
Debt
Debt current
(103)
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(2,226)
(2,189)
(4,060)
Cash flow
Cash from operating activities
(162)
(1,763)
(9,756)
CAPEX
(3)
Cash from investing activities
98
39
(2)
Cash from financing activities
100
(4)
10,335
FCF
655
581
(15,748)
Balance
Cash
2,226
2,189
3,957
Long term investments
Excess cash
2,226
2,115
3,667
Stockholders' equity
2,020
2,782
4,566
Invested Capital
667
797
ROIC
ROCE
EV
Common stock shares outstanding
167,040
167,040
152,688
Price
0.01
-47.62%
0.02
-30.00%
0.03
-82.35%
Market cap
1,837
-47.62%
3,508
-23.42%
4,581
-75.93%
EV
(389)
1,318
521
EBITDA
(1,788)
(9,160)
EV/EBITDA
Interest
33
115
Interest/NOPBT